AWN AAA Special Issue: Faster! Faster! Intelligence won´t wait

Sivantos and Widex

Sivantos and Widex merge to become WS Audiology

Sivantos and Widex

iHear launches pay-as-you-go aids on subscription with online tweaking and support

Get the latest news of the profession: sign up for our newsletter!

Audiology Worldnews newsletter

Interested in Audiology-related events?

Audiology Worldnews agenda

TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent

Photo: Lasse Designen - Fotolia
'Contact lens' for the ear project on cusp of clinical testing
'Contact lens' for the ear project on cusp of clinical testing


Dr. Dominik Kaltenbacher © Vibrosonic

A "completely new alternative to a normal hearing device"—an eardrum-hugging disc using a piezoelectric transducer and labelled by its inventors a "contact lens" for the ear—now has the home straight of its development in sight.

EUHA 2019: Watch the trailer and save the date!
EUHA 2019: Watch the trailer and save the date!


The 64th International Congress of Hearing Aid Acousticians and Trade Exhibition will take place 16-18 October 2019 in Nürnberg.

Are patients with psoriatic arthritis at risk for hearing loss?
Are patients with psoriatic arthritis at risk for hearing loss?


© Nick Youngson CC BY-SA 3.0 Alpha Stock Images

A first-ever multicentred study to evaluate hearing in psoriatic arthritis (PsA) suggests clinicians should be aware that patients with this skin condition may be at risk of developing hearing loss.

NICE criteria review means 70% more NHS cochlear implants annually in UK by 2024
NICE criteria review means 70% more NHS cochlear implants annually in UK by 2024


© Mingasson-Advanced Bionics

A significant rise in the number of UK NHS patients receiving cochlear implants (CIs) will follow a long-overdue criteria revision by the standards-setting body NICE.

New regional ENT plan for the Pacific
New regional ENT plan for the Pacific

Public health


Australian and New Zealand ENT and Audiology experts have been meeting this spring with their counterparts from 6 Pacific Islands to help develop a plan to tackle an alarming regional shortage in hearing health equipment and workforce.

To be, or not to be … together?
To be, or not to be … together?

Joint conference

© V.A.

The second collaborative conference with the British Academy of Audiology (BAA) and British Society of Audiology (BSA) and the British Society of Hearing Aid Audiologists (BSHAA) – Hearing: A Sense of Purpose – took place in Bristol on 25 March.

Auditory nerve implant research wins $9.7m US health grant
Auditory nerve implant research wins $9.7m US health grant


© Philol - Fotolia

A sizeable research grant from the US National Institutes for Health (NIH) has set up the University of Minnesota to lead a global project into developing a different kind of implant to the cochlear variety, one that can restore normal hearing.

Company Directory

New products

Auditdata: tools to excel in businessAuditdata: tools to excel in business


As the global hearing profession faces change and what seems to be many threats, we think it is imperative that businesses have access to the best tools and data. [ ... ]

Oticon launches groundbreaking Oticon Opn SOticon launches groundbreaking Oticon Opn S

© Oticon

Oticon Opn S takes the open sound experience and the unique benefits of BrainHearing™ to the next level, and features the world’s first system to [ ... ]

Oticon Opn Play™ Premium a breakthrough in paediatric hearing care Oticon Opn Play™ Premium a breakthrough in paediatric hearing care

© Oticon

Oticon Opn Play™ breaks with conventional hearing technology by opening up a new world of sound for children and ensures  [ ... ]